{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:44:28Z","timestamp":1784673868690,"version":"3.55.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H25-Shinko-Shitei-009"],"award-info":[{"award-number":["H25-Shinko-Shitei-009"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16fk0108002j"],"award-info":[{"award-number":["16fk0108002j"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17fk0108202j"],"award-info":[{"award-number":["17fk0108202j"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18fk0108002j"],"award-info":[{"award-number":["18fk0108002j"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19fk0108072j"],"award-info":[{"award-number":["19fk0108072j"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19fk0108081j"],"award-info":[{"award-number":["19fk0108081j"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00150","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T04:35:48Z","timestamp":1581395748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":82,"title":["Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection"],"prefix":"10.3389","volume":"11","author":[{"given":"Mutsuyo","family":"Takayama-Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/2040206617740303","article-title":"Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors","volume":"25","author":"Baba","year":"2017","journal-title":"Antivir. Chem. Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1128\/AAC.48.4.1422-1425.2004","article-title":"2'-fluoro-2'-deoxycytidine inhibits Borna disease virus replication and spread","volume":"48","author":"Bajramovic","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.antiviral.2016.11.015","article-title":"Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus","volume":"137","author":"Balasubramanian","year":"2017","journal-title":"Antiviral Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","article-title":"Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance","volume":"8","author":"Beaucourt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antiviral Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"E3309","DOI":"10.3390\/molecules23123309","article-title":"The impact of coffee and its selected bioactive compounds on the development and progression of colorectal cancer in vivo and in vitro","volume":"23","author":"Bu\u0142dak","year":"2018","journal-title":"Molecules"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1099\/vir.0.041053-0","article-title":"Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents","volume":"93","author":"Chen","year":"2012","journal-title":"J. Gen. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0005264","DOI":"10.1371\/journal.pntd.0005264","article-title":"Severe fever with thrombocytopenia syndrome in South Korea, 2013-2015","volume":"10","author":"Choi","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D","article-title":"Chlorogenic acids and other cinnamates\u2013 nature, occurrence and dietary burden","volume":"79","author":"Clifford","year":"1999","journal-title":"J. Sci. Food. Agric."},{"key":"B10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/d41586-018-04486-6","article-title":"East Asia braces for surge in deadly tick-borne virus news","volume":"556","author":"Cyranoski","year":"2018","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S588","DOI":"10.1093\/infdis\/jiy332","article-title":"The calcium channel blocker bepridil demonstrates efficacy in the murine model of marburg virus disease","volume":"22","author":"Dewald","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep45723","article-title":"Antiviral activity of chlorogenic acid against influenza A (H1N1\/H3N2) virus and its inhibition of neuraminidase","volume":"7","author":"Ding","year":"2017","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41541-018-0096-y","article-title":"Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus","volume":"4","author":"Dong","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrd.2016.173","article-title":"Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection","volume":"15","author":"Ferrari","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"B17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/cid\/cir776","article-title":"Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact","volume":"54","author":"Gai","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504605","article-title":"Effect of artesunate.amodiaquine on mortality related to Ebola virus disease","volume":"374","author":"Gignoux","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"Goldhill","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12275-017-7029-8","article-title":"Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies","volume":"55","author":"Gowen","year":"2017","journal-title":"J. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e01942","DOI":"10.1128\/JVI.01942-16","article-title":"Modeling severe fever with thrombocytopenia syndrome virus infection in golden syrian hamsters: importance of STAT2 in preventing disease and effective treatment with favipiravir","volume":"91","author":"Gowen","year":"2017","journal-title":"J. Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.febslet.2004.08.015","article-title":"Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV","volume":"574","author":"Hsu","year":"2004","journal-title":"FEBS Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/infdis\/jiu564","article-title":"SFTS virus infection in nonhuman primates","volume":"211","author":"Jin","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"10053","DOI":"10.1073\/pnas.1120246109","article-title":"Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57\/BL6 mouse model","volume":"109","author":"Jin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0165207","DOI":"10.1371\/journal.pone.0165207","article-title":"Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013-2014","volume":"11","author":"Kato","year":"2016","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.7883\/yoken.JJID.2018.526","article-title":"A case of cat-to-human transmission of severe fever with thrombocytopenia syndrome virus","volume":"72","author":"Kida","year":"2019","journal-title":"Jpn. J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1007375","DOI":"10.1371\/journal.ppat.1007375","article-title":"An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus","volume":"15","author":"Kim","year":"2019","journal-title":"PLoS Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3201\/eid1911.130792","article-title":"Severe fever with thrombocytopenia syndrome, South Korea, 2012","volume":"19","author":"Kim","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/j.1552-4604.1973.tb00196.x","article-title":"Review of the toxicity of hexachlorophene, including its neurotoxicity","volume":"13","author":"Kimbrough","year":"1973","journal-title":"J. Clini. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.antiviral.2011.09.001","article-title":"In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections","volume":"92","author":"Kumaki","year":"2011","journal-title":"Antiviral Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11815-4","article-title":"Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets","volume":"10","author":"Kwak","year":"2019","journal-title":"Nat. Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.antiviral.2018.10.021","article-title":"Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses","volume":"160","author":"Langland","year":"2018","journal-title":"Antiviral Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"204r","DOI":"10.1126\/scitranslmed.3006827","article-title":"siRNA screen for genes that affect Jun\u00edn virus entry uncovers voltage-gated calcium channels as a therapeutic target","volume":"5","author":"Lavanya","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3904\/kjim.2016.109","article-title":"In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011\u201317: a prospective observational study","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","article-title":"Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality","volume":"29","author":"Li","year":"2019","journal-title":"Cell Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/cid\/cit530","article-title":"Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome","volume":"57","author":"Liu","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1128\/JVI.02277-13","article-title":"The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha\/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever","volume":"88","author":"Liu","year":"2014","journal-title":"J. Virol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.antiviral.2015.04.006","article-title":"Common adverse events associated with ribavirin therapy for Severe fever with thrombocytopenia syndrome","volume":"119","author":"Lu","year":"2015","journal-title":"Antiviral Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2217\/imt-2017-0010","article-title":"The ongoing evolution of antibody-based treatments for Ebola virus infection","volume":"9","author":"Mendoza","year":"2017","journal-title":"Immunotherapy"},{"key":"B43","first-page":"193","article-title":"Guideline for prevention and treatment of severe fever with thrombocytopenia syndrome (2010 version)","volume":"4","year":"2011","journal-title":"Chinese J. Clin. Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal influenza virus vaccines and therapeutic antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"B45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jiac.2017.11.004","article-title":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome","volume":"24","author":"Nakamura","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fimmu.2019.01182","article-title":"Interferon-\u03b3-directed inhibition of a novel high-pathogenic phlebovirus and viral antagonism of the antiviral signaling by targeting STAT1","volume":"10","author":"Ning","year":"2019","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3201\/eid1905.120245","article-title":"Severe fever with thrombocytopenia syndrome virus among domesticated animals, China","volume":"19","author":"Niu","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jiac.2018.03.005","article-title":"Caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitro","volume":"24","author":"Ogawa","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijid.2013.08.011","article-title":"Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome","volume":"18","author":"Oh","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuro.2016.08.011","article-title":"Longitudinal diffusion tensor imaging of the rat brain after hexachlorophene exposure","volume":"56","author":"Ramu","year":"2016","journal-title":"Neurotoxicology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jiac.2018.07.009","article-title":"Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy","volume":"24","author":"Saijo","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.antiviral.2018.10.025","article-title":"Novel amodiaquine derivatives potently inhibit Ebola virus infection","volume":"160","author":"Sakurai","year":"2018","journal-title":"Antiviral Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.1128\/JVI.00144-10","article-title":"Virus-induced Ca2+ influx extends survival of west nile virus-infected cells","volume":"84","author":"Scherbik","year":"2010","journal-title":"J. Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virol.2015.03.010","article-title":"Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection","volume":"482","author":"Shimada","year":"2015","journal-title":"Virology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12985-015-0412-3","article-title":"Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection","volume":"12","author":"Shimojima","year":"2015","journal-title":"Virol. J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.7883\/yoken.67.423","article-title":"Effects of ribavirin on severe fever with thrombocytopenia syndrome virus in vitro","volume":"67","author":"Shimojima","year":"2014","journal-title":"Jpn. J. Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.antiviral.2018.10.013","article-title":"2\u2032-Fluoro-2\u2032-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models","volume":"160","author":"Smee","year":"2018","journal-title":"Antiviral Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1517\/14656566.2.8.1317","article-title":"Ribavirin - current status of a broad spectrum antiviral agent","volume":"2","author":"Snell","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"B60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.antiviral.2017.11.019","article-title":"Second international conference on Crimean-Congo hemorrhagic fever","volume":"150","author":"Spengler","year":"2018","journal-title":"Antiviral Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/infdis\/jit603","article-title":"The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan","volume":"209","author":"Takahashi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"7599","DOI":"10.1038\/s41598-017-07953-8","article-title":"Anti-colon cancer effect of caffeic acid p-nitro-phenethyl ester in vitro and in vivo and detection of its metabolites","volume":"7","author":"Tang","year":"2017","journal-title":"Sci. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e00061","DOI":"10.1128\/mSphere.00061-15","article-title":"Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus","volume":"1","author":"Tani","year":"2016","journal-title":"mSphere"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0206416","DOI":"10.1371\/journal.pone.0206416","article-title":"Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: dose-efficacy studies upon oral administration","volume":"13","author":"Tani","year":"2018","journal-title":"PLoS ONE"},{"key":"B65","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.imbio.2005.07.003","article-title":"Sources of interferon-gamma (IFN-\u03b3) in early immune response to Listeria monocytogenes","volume":"210","author":"Th\u00e4le","year":"2005","journal-title":"Immunobiology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3201\/eid2505.181463","article-title":"Endemic severe fever with thrombocytopenia syndrome, Vietnam","volume":"25","author":"Tran","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3892\/ijmm.2014.1859","article-title":"Inhibition by caffeic acid of the influenza a virus multiplication in vitro","volume":"34","author":"Utsunomiya","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.antiviral.2009.05.002","article-title":"Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro","volume":"83","author":"Wang","year":"2009","journal-title":"Antiviral Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e01055","DOI":"10.1128\/JVI.01055-17","article-title":"Screening of FDA-approved drugs for inhibitors of Japanese encephalitis virus infection","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.antiviral.2016.10.007","article-title":"Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems","volume":"136","author":"Welch","year":"2016","journal-title":"Antiviral Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.antiviral.2017.10.008","article-title":"Identification of 2\u2032-deoxy-2\u2032-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus","volume":"147","author":"Welch","year":"2017","journal-title":"Antiviral Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0167-4781(85)90053-3","article-title":"The effect of 2\u2032-fluoro-2\u2032-deoxycytidine on herpes virus growth","volume":"824","author":"Wohlrab","year":"1985","journal-title":"Biochim. Biophys. Acta"},{"key":"B73","unstructured":"Annual Review of Diseases Prioritized Under the Research and Development Blueprint, 20172017"},{"key":"B74","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3904\/kjim.2016.194","article-title":"Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome","volume":"34","author":"Yoo","year":"2019","journal-title":"Korean J. Intern. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e02226","DOI":"10.1128\/JVI.02226-18","article-title":"Species-specific pathogenicity of severe fever with thrombocytopenia syndrome virus is determined by anti-STAT2 activity of NSs","volume":"93","author":"Yoshikawa","year":"2019","journal-title":"J. Virol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"E385","DOI":"10.3390\/v11040385","article-title":"Screening of an FDA-approved drug library with a two-tier system identifies an entry inhibitor of severe fever with thrombocytopenia syndrome virus","volume":"11","author":"Yuan","year":"2019","journal-title":"Viruses"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1080\/22221751.2019.1645573","article-title":"First case of laboratory-confirmed severe fever with thrombocytopenia syndrome disease revealed the risk of SFTSV infection in Xinjiang, China","volume":"8","author":"Zhu","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"B79","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/pathogens2020402","article-title":"Animal models of tick-borne hemorrhagic fever viruses","volume":"2","author":"Zivcec","year":"2013","journal-title":"Pathogens"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T04:35:52Z","timestamp":1581395752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":79,"alternative-id":["10.3389\/fmicb.2020.00150"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00150","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"article-number":"150"}}